DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Common Equity (2017 - 2026)

Updated

DiaMedica Therapeutics' Common Equity was $38.34 million in Q2 2026, up 41.1% from $27.17 million a year earlier but down 18.8% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Common Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at DiaMedica Therapeutics came in at $56.11 million, up 37.8% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 16.6% (FY2020 to FY2025).
  • In earlier years, Common Equity was $40.72 million in FY2024 (-20.2%), $51.06 million in FY2023 (+60.4%), $31.83 million in FY2022 (-27.7%) and $44.02 million in FY2021 (+69.2%).
  • Quarterly Common Equity has moved between $27.02 million (Q1 2023) and $59.74 million (Q2 2023) over five years.
  • Compared with a year earlier, Common Equity has increased for four straight quarters, with growth averaging 2.0% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q2 2022 (growth of 85.6%); the worst was Q2 2025 (a decline of 49.1%).
  • Per Business Quant data, DMAC's Common Equity in the three quarters before Q2 2026 was $47.24 million (Q1 2026), $56.11 million (Q4 2025) and $51.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 84.97 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.94 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.37 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.25 Bn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 38.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.34 Mn
Mar 31, 2026 47.24 Mn
Dec 31, 2025 56.11 Mn
Sep 30, 2025 51.62 Mn
Jun 30, 2025 27.17 Mn
Mar 31, 2025 33.95 Mn
Dec 31, 2024 40.72 Mn
Sep 30, 2024 47.96 Mn
Jun 30, 2024 53.42 Mn
Mar 31, 2024 46.35 Mn
Dec 31, 2023 51.06 Mn
Sep 30, 2023 55.63 Mn
Jun 30, 2023 59.74 Mn
Mar 31, 2023 27.02 Mn
Dec 31, 2022 31.83 Mn
Sep 30, 2022 35.08 Mn
Jun 30, 2022 37.72 Mn
Mar 31, 2022 40.77 Mn
Dec 31, 2021 44.02 Mn
Sep 30, 2021 47.04 Mn
API Access

DiaMedica Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DMAC&period=max&api_key=YOUR_API_KEY